Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-01-05Clinical Trial Update: Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanning [Phase 4]
Phase 4 clinical trial evaluating the diagnostic performance of Prostate HistoScanning for guided biopsy in prostate cancer; the study has b…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Comparing Two Sets of Bladder-Filling Instructions in Treating Patients Undergoing Radiation Therapy For Prostate Cancer. ICORG 05-04 [NA]
The trial ICORG 05-04 compared two bladder-filling instruction protocols for patients undergoing radiation therapy for prostate cancer; the …
-
CLINICAL_TRIALS trial_result · 2014-12-24Clinical Trial Update: F-18 Sodium Fluoride in Prostate Cancer [Phase 2]
Phase 2 trial evaluating F-18 Sodium Fluoride for imaging in prostate cancer has completed. Results were posted on 2014-12-24.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2 [NA]
This document notes the completion of Study 2 for the Decision Support Interventions for Prostate Cancer Screening and Treatment trial. It i…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluating R-(-)-Gossypol in combination with androgen ablation for newly diagnosed metastatic prostate cancer has completed. …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-12-16Clinical Trial Update: Degarelix Before Radical Prostatectomy [EARLY_Phase 1]
Early-phase 1 trial update evaluating degarelix before radical prostatectomy for prostate cancer. The trial status is currently unknown.
-
FDA approval · 2014-12-15FDA Approved: FIRMAGON — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for FIRMAGON (degarelix) by Ferring Pharmaceuticals Inc. This action represents an additional regula…
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography [EARLY_Phase 1]
Early-phase (Phase 1) clinical trial evaluating the copper-64 radiotracer 64Cu-DOTA-AE105 for diagnosing aggressive cancers with PET; the st…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Early Assessment of Treatment Response Using Functional Diffusion Mapping [NA]
This clinical trial update reports completion of a study evaluating Functional Diffusion Mapping as an early indicator of treatment response…
-
CLINICAL_TRIALS withdrawal · 2014-12-08Clinical Trial Update: Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management
A clinical trial evaluating active surveillance with or without MRI-guided management for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-11-26Clinical Trial Update: Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants [Phase 1]
Phase 1 clinical trial update evaluating Se-Methyl-Seleno-L-Cysteine or Selenomethionine for preventing prostate cancer in healthy participa…
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer [Phase 1]
A phase 1 study evaluating the addition of everolimus to combined hormonal therapy and radiation for high-risk prostate cancer was terminate…
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer [Phase 1, Phase 2]
This clinical trial update reports results from Phase 1/2 studies measuring anti‑androgen response in androgen-insensitive prostate cancer u…
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Prostate Biomarkers in Men Consuming Tomato Products [NA]
The clinical trial investigating prostate biomarkers in men consuming tomato products has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC) [Phase 1, Phase 2]
Clinical trial update shows completion of a Phase I/II study of ODX (Osteodex) in metastatic castration-resistant prostate cancer.
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer [Phase 2]
Phase 2 trial update on radiation therapy for stage II/III prostate cancer; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Protection of Rectum From High Radiation Doses [NA]
This clinical trial update reports completed results from a study on protecting the rectum from high radiation doses during prostate cancer …
-
CLINICAL_TRIALS research · 2014-11-14Clinical Trial Update: SmartTarget THERAPY [NA]
Clinical trial update for SmartTarget THERAPY in prostate cancer; status details are not provided.
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling [NA]
This clinical trial update reports results from a study evaluating return of continence after robot-assisted radical prostatectomy with or w…
-
FDA approval · 2014-11-10FDA Approved: FIRMAGON — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for FIRMAGON (degarelix) from Ferring Pharmaceuticals, potentially updating its labeling or expandin…
-
CLINICAL_TRIALS trial_result · 2014-11-10Clinical Trial Update: Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer [Phase 3]
Phase 3 trial evaluating zoledronic acid with vitamin D and calcium, with or without radiopharmaceuticals strontium-89 or samarium-153, to p…
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: Prothrombotic Factors and Anaesthesia in Prostate Cancer [NA]
Clinical trial update on prothrombotic factors and anaesthesia in prostate cancer; study status completed.
-
FDA approval · 2014-11-05FDA Approved: DOCETAXEL — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approves the original (ANDA) application for docetaxel generic produced by Dr. Reddy's Laboratories.
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial [Phase 2]
A Phase II clinical trial evaluating single-fraction HDR brachytherapy combined with hypofractionated external beam radiotherapy for low-ris…
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 safety study of autologous dendritic cells injected into the prostate after cryoablation in advanced prostate cancer was terminate…